US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
US6514238B1
(en)
|
1989-08-14 |
2003-02-04 |
Photogenesis, Inc. |
Method for preparation and transplantation of volute grafts and surgical instrument therefor
|
US5817075A
(en)
*
|
1989-08-14 |
1998-10-06 |
Photogenesis, Inc. |
Method for preparation and transplantation of planar implants and surgical instrument therefor
|
SG49267A1
(en)
|
1989-08-14 |
1998-05-18 |
Photogenesis Inc |
Surgical instrument and cell isolation and transplantation
|
US6045791A
(en)
*
|
1992-03-06 |
2000-04-04 |
Photogenesis, Inc. |
Retinal pigment epithelium transplantation
|
JP3720386B2
(en)
*
|
1993-12-27 |
2005-11-24 |
住友製薬株式会社 |
Drug release controlled formulation
|
US5618274A
(en)
*
|
1994-04-08 |
1997-04-08 |
Rosenthal; Kenneth J. |
Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia
|
US5868728A
(en)
*
|
1995-02-28 |
1999-02-09 |
Photogenesis, Inc. |
Medical linear actuator for surgical delivery, manipulation, and extraction
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
AU729870B2
(en)
*
|
1997-03-31 |
2001-02-15 |
Alza Corporation |
Diffusional implantable delivery system
|
US6196993B1
(en)
*
|
1998-04-20 |
2001-03-06 |
Eyelab Group, Llc |
Ophthalmic insert and method for sustained release of medication to the eye
|
EP1154691A4
(en)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
CN1292721C
(en)
*
|
1999-10-21 |
2007-01-03 |
爱尔康公司 |
Drug delivery device
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
PT1221918E
(en)
|
1999-10-21 |
2005-06-30 |
Alcon Inc |
ADMINISTRATION OF SUB-TENON DRUGS
|
US6264971B1
(en)
|
1999-11-04 |
2001-07-24 |
Btg International Limited |
Ocular insert
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
ES2312456T3
(en)
*
|
2000-08-30 |
2009-03-01 |
Johns Hopkins University |
DEVICES FOR INTRAOCULAR SUPPLY OF PHARMACOS.
|
DE60114229T2
(en)
*
|
2000-11-29 |
2006-07-06 |
Allergan, Inc., Irvine |
PREVENTING TRANSPLANT DISCHARGE IN THE EYE
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
EP2316394B1
(en)
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
WO2003009784A1
(en)
*
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
CN1203814C
(en)
|
2001-07-23 |
2005-06-01 |
爱尔康公司 |
Opthalmic drug delivery device
|
EP1418864A4
(en)
*
|
2001-08-03 |
2009-07-01 |
Research Technologies Glaucoma |
Method and intra sclera implant for treatment of glaucoma and presbyopia
|
GB2399020B
(en)
*
|
2002-02-14 |
2005-01-12 |
Photogenesis Inc |
Subretinal implantation device and surgical cannulas for use therewith
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
NZ540885A
(en)
*
|
2002-12-20 |
2009-02-28 |
Chakshu Res Inc |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US8246974B2
(en)
*
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
DE602004028638D1
(en)
*
|
2003-05-02 |
2010-09-23 |
Surmodics Inc |
System for the controlled release of a bioactive agent in the back of the eye
|
CA2522592A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
JP4869930B2
(en)
*
|
2003-08-26 |
2012-02-08 |
ヴィスタ サイエンティフィック エルエルシー |
Ophthalmic drug supply device
|
CN102813923B
(en)
*
|
2003-08-27 |
2015-04-01 |
奥普索特克公司 |
Combination therapy for the treatment of ocular neovascular disorders
|
US7585517B2
(en)
*
|
2003-09-18 |
2009-09-08 |
Macusight, Inc. |
Transscleral delivery
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
EP2377569A1
(en)
*
|
2004-07-02 |
2011-10-19 |
QLT Plug Delivery, Inc. |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
EP1781264B1
(en)
|
2004-08-04 |
2013-07-24 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
US7722669B2
(en)
*
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
EP1819325A2
(en)
*
|
2004-12-22 |
2007-08-22 |
Alcon, Inc. |
Device for ophthalmic drug delivery
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
DK1848431T3
(en)
*
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
JP2008535847A
(en)
*
|
2005-04-08 |
2008-09-04 |
サーモディクス,インコーポレイティド |
Sustained release implant for subretinal delivery
|
BRPI0615962A2
(en)
|
2005-07-27 |
2011-05-31 |
Univ Florida |
use of a compound selected from the group consisting of a proteasome inhibitor, an autophagy inhibitor, a lysosomal inhibitor, an golgi er protein transport inhibitor, an hsp90 chaperonin inhibitor, a heat shock response activator, a and a histone deacetylase inhibitor, use of 11-cis-retinal or 9-cis-retinal and a compound selected from the group consisting of a proteasome inhibitor, an autophagy inhibitor, a lissosomal inhibitor, a er to golgi protein, a hsp90 chaperonin inhibitor, a heat shock response activator, a glycosidase inhibitor, and a histone deacetylase inhibitor, a method for increasing the amount of a biochemically functional conformation of a protein in a cell, composition pharmaceutical for the treatment of an ocular pcd, pharmaceutical composition for the treatment of retinitis pigmentosa, kit for the treatment of an ocular pcd, kit for the treatment retinitis pigmentosa, method for identifying a compound useful for the treatment of an individual having an ocular pcd, method for identifying a compound useful for the treatment of an individual having retinitis pigmentosa, use of a proteasome inhibitor or a autophagy inhibitor and method for producing a recombinant protein in a biochemically functional conformation
|
EP2182078B1
(en)
*
|
2005-09-01 |
2012-02-01 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
|
EA016227B1
(en)
|
2005-11-29 |
2012-03-30 |
Смитклайн Бичем Корпорейшн |
Method of treating ocular neovascular disorders
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
JP5528708B2
(en)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
Stable formulations and methods for preparing and using them
|
CN101443004B
(en)
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
Formulations and methods for vascular permeability-related diseases or conditions
|
CN103393483B
(en)
|
2006-03-31 |
2016-08-24 |
玛提治疗有限公司 |
Medicine release method, structure and composition for nose tear system
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8828419B2
(en)
*
|
2006-10-06 |
2014-09-09 |
Cordis Corporation |
Bioabsorbable device having encapsulated additives for accelerating degradation
|
US8394488B2
(en)
|
2006-10-06 |
2013-03-12 |
Cordis Corporation |
Bioabsorbable device having composite structure for accelerating degradation
|
CA2674076A1
(en)
*
|
2006-12-26 |
2008-07-10 |
Qlt Plug Delivery, Inc. |
Drug delivery implants for inhibition of optical defects
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
MX2010002616A
(en)
*
|
2007-09-07 |
2010-08-04 |
Qlt Plug Delivery Inc |
Drug cores for sustained release of therapeutic agents.
|
EP3372205A1
(en)
|
2007-09-07 |
2018-09-12 |
Mati Therapeutics Inc. |
Lacrimal implant detection
|
EP2205191B1
(en)
|
2007-09-07 |
2014-11-12 |
Mati Therapeutics Inc. |
Lacrimal implant
|
CN102670352A
(en)
*
|
2007-09-07 |
2012-09-19 |
Qlt股份有限公司 |
Insertion and extraction tools for lacrimal implants
|
TWI498136B
(en)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
An injection device for delivering a rate and temperature-dependent substance into the eye and method of preparing the same
|
TWI451862B
(en)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
Thermal coefficient driven drug pellet size for ophthalmic injection
|
EP2222281B1
(en)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
MX2010008998A
(en)
*
|
2008-02-18 |
2010-11-26 |
Qlt Plug Delivery Inc |
Lacrimal implants and related methods.
|
CN104623741A
(en)
|
2008-04-30 |
2015-05-20 |
马缇医疗股份有限公司 |
Composite lacrimal insert and related methods
|
CA2722971C
(en)
*
|
2008-05-09 |
2019-05-07 |
Qlt Plug Delivery, Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
US20100189765A1
(en)
*
|
2008-11-26 |
2010-07-29 |
Erickson Signe R |
Implantable ocular drug delivery device and methods
|
WO2010088548A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Labs, Llc |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
JP5576405B2
(en)
*
|
2009-02-23 |
2014-08-20 |
キュー エル ティー インク. |
Lacrimal implant and related methods
|
WO2010101758A1
(en)
*
|
2009-03-03 |
2010-09-10 |
Alcon Research, Ltd. |
Peri-corneal drug delivery device
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
CN105726201B
(en)
*
|
2009-05-18 |
2020-08-25 |
多斯医学公司 |
Drug delivery ocular implant
|
WO2010141729A1
(en)
*
|
2009-06-03 |
2010-12-09 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
IN2012DN00352A
(en)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
BR112012006443A2
(en)
*
|
2009-09-22 |
2017-07-25 |
Evonik Degussa Corp |
implant devices that feature variable loading configurations of bioactive agents
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
EP2486128A4
(en)
*
|
2009-10-08 |
2013-10-09 |
Neurotech Usa Inc |
Use of pedf in an encapsulated cell-based delivery system
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
US8469934B2
(en)
*
|
2010-01-27 |
2013-06-25 |
Alcon Research, Ltd. |
Pulsatile peri-corneal drug delivery device
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
PL2600812T3
(en)
|
2010-08-05 |
2022-01-24 |
Forsight Vision4, Inc. |
Apparatus to treat an eye
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
CN105435338B
(en)
|
2010-08-05 |
2019-03-26 |
弗赛特影像4股份有限公司 |
Injector apparatus and method for drug conveying
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US20120157938A1
(en)
*
|
2010-12-16 |
2012-06-21 |
Tokarski Jason M |
Punctal plug with drug core retention features
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
DK3290024T3
(en)
|
2011-08-29 |
2019-06-03 |
Mati Therapeutics Inc |
CONTINUING SUBMISSION OF ACTIVE RESOURCES FOR TREATMENT OF GLAUCUM AND OCULAR HYPERTENSION
|
US9102105B2
(en)
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
CN106073986B
(en)
|
2011-09-14 |
2019-01-11 |
弗赛特影像5股份有限公司 |
The device for treating the eyes of patient
|
SI2755600T1
(en)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
US9499464B2
(en)
|
2011-10-19 |
2016-11-22 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
EP2785346A4
(en)
|
2011-11-30 |
2015-04-29 |
Bikam Pharmaceuticals Inc |
Opsin-binding ligands, compositions and methods of use
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013086015A1
(en)
|
2011-12-05 |
2013-06-13 |
Incept, Llc |
Medical organogel processes and compositions
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US9308355B2
(en)
|
2012-06-01 |
2016-04-12 |
Surmodies, Inc. |
Apparatus and methods for coating medical devices
|
WO2014066775A1
(en)
|
2012-10-26 |
2014-05-01 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
DK2956476T3
(en)
|
2013-02-18 |
2020-02-17 |
Vegenics Pty Ltd |
LANDAND-BINDING MOLECULES AND APPLICATIONS THEREOF
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
CN105246438B
(en)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
For conveying the ophthalmic implant of therapeutic substance
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
KR20220061248A
(en)
|
2013-07-12 |
2022-05-12 |
이베릭 바이오, 인크. |
Methods for treating or preventing ophthalmological conditions
|
MY182497A
(en)
|
2014-07-15 |
2021-01-25 |
Forsight Vision4 Inc |
Ocular implant delivery device and method
|
BR112017002466A2
(en)
|
2014-08-08 |
2017-12-05 |
Forsight Vision4 Inc |
stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods for their preparation
|
WO2016031093A1
(en)
*
|
2014-08-28 |
2016-03-03 |
株式会社ユニバーサルビュー |
Ocular insert device
|
JP5643460B1
(en)
*
|
2014-08-28 |
2014-12-17 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
JP5643461B1
(en)
*
|
2014-08-28 |
2014-12-17 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
JP5671183B1
(en)
*
|
2014-08-28 |
2015-02-18 |
株式会社ユニバーサルビュー |
Eyelid interior tools
|
SG11201703726XA
(en)
|
2014-11-10 |
2017-06-29 |
Forsight Vision4 Inc |
Expandable drug delivery devices and method of use
|
WO2016168141A1
(en)
|
2015-04-13 |
2016-10-20 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
KR20180084104A
(en)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
Porous structures for extended release drug delivery devices
|
JP7009384B2
(en)
|
2016-04-05 |
2022-01-25 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
Implantable eye drug delivery device
|
US10383764B2
(en)
*
|
2016-10-31 |
2019-08-20 |
Ebrahim Elahi |
Eyelid implant device
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
US20200268554A1
(en)
*
|
2018-05-12 |
2020-08-27 |
Goldenbiotech, Llc |
Self-Retaining Implantable Drug Delivery Device
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US20210169690A1
(en)
*
|
2019-12-10 |
2021-06-10 |
Goldenbiotech, Llc |
Self-Retaining Implantable Drug Delivery Device
|
AU2022272319A1
(en)
*
|
2021-05-14 |
2023-12-07 |
Glaukos Corporation |
Materials and methods for punctal plugs
|
WO2023073706A1
(en)
*
|
2021-10-27 |
2023-05-04 |
Avisi Ltd. |
Ophthalmic device
|